rs397515823
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000138.5(FBN1):c.5512G>T(p.Gly1838Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/19 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1838S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Marfan syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
- Acromicric dysplasiaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- progeroid and marfanoid aspect-lipodystrophy syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- stiff skin syndromeInheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Weill-Marchesani syndrome 2, dominantInheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- geleophysic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated ectopia lentisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal Marfan syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Weill-Marchesani syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ectopia lentis 1, isolated, autosomal dominantInheritance: AD Classification: LIMITED Submitted by: G2P
- Shprintzen-Goldberg syndromeInheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000138.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FBN1 | NM_000138.5 | MANE Select | c.5512G>T | p.Gly1838Cys | missense | Exon 45 of 66 | NP_000129.3 | ||
| FBN1 | NM_001406716.1 | c.5512G>T | p.Gly1838Cys | missense | Exon 44 of 65 | NP_001393645.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FBN1 | ENST00000316623.10 | TSL:1 MANE Select | c.5512G>T | p.Gly1838Cys | missense | Exon 45 of 66 | ENSP00000325527.5 | ||
| FBN1 | ENST00000559133.6 | TSL:1 | n.5512G>T | non_coding_transcript_exon | Exon 45 of 67 | ENSP00000453958.2 | |||
| FBN1 | ENST00000537463.6 | TSL:5 | n.*1275G>T | non_coding_transcript_exon | Exon 20 of 31 | ENSP00000440294.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Marfan syndrome Pathogenic:2
The p.Gly1838Cys variant in FBN1 has been identified in 3 individuals with clini cal features of Marfan syndrome (Ganesh 2006, Beatens 2011, LMM data) and was ab sent from large population studies. Computational prediction tools and conservat ion analysis suggest that the p.Gly1838Cys variant may impact the protein, thoug h this information is not predictive enough to determine pathogenicity. In addit ion, one study observed abnormal fibril patterns using firbilin-1 staining in ti ssue from an individual who carried this variant (Ganesh 2006). In summary, alth ough additional studies are required to fully establish its clinical significanc e, the p.Gly1838Cys variant is likely pathogenic. ACMG/AMP Criteria applied: PM2 ; PS4_Moderate; PP3; PS3_Supporting (Richards 2015).
PM2, PS5, PP4
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections Pathogenic:1
Variant Summary: The FBN1 c.5512G>T (p.Gly1838Cys) variant causes a missense change involving a conserved nucleotide with 4/4 in silico programs (SNPs&GO not captured here due to low reliability index) predicting a "deleterious" outcome, although these predictions have yet to be functionally assessed. However, this missense mutation involved a highly conserved Gly residue, replacing it with a Cys. "The sulfhydryl group of cysteine is unique in its ability to participate in disulfide covalent cross-linkage . In fact, two thirds of fibrillin cysteine residues exist in the half-cystinyl form, suggesting their participation in intramolecular disulfide linkage. The cysteine residues in the EGF-like motif may also be necessary for intermolecular interactions with other fibrillin molecules or with other proteins (Dietz_1992)." Therefore, a missense change to a cysteine residue could disrupt normal disulfide binding, effecting secondary or tertiary structure, or possibly impairing fibrillin interactions. In addition, the variant of interest was absent in 121354 control chromosomes, has been reported in affected individuals via publications, and one clinical lab has classified the variant as pathogenic. Therefore, taking all available lines of evidence, the variant of interest is classified as Likely Pathogenic until additional information becomes available.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at